Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.

JS, Miser; RE, Goldsby; Z, Chen; MD, Krailo; NJ, Tarbell; MP, Link; CJ, Fryer; DJ, Pritchard; MC, Gebhardt; PS, Dickman; EJ, Perlman; PA, Meyers; SS, Donaldson; SG, Moore; AR, Rausen; TJ, Vietti; HE, Grier

doi:10.1002/pbc.21233

Public

Treatment of metastatic Ewing sarcoma/primitive neuroectodermal tumor of bone: evaluation of increasing the dose intensity of chemotherapy--a report from the Children's Oncology Group.

Shared by NobleBlocks on Dec 1, 2007 • 12:00 AM UTC

Authors:

Miser JS

Goldsby RE

Chen Z

Abstract

Background The outcome for patients with Ewing sarcoma family of tumors (ESFTs) of bone with metastases at diagnosis remains poor despite new approaches to treatment. We evaluated whether a dose-intensity chemotherapy regimen improved survival for patients with ESFTs of bone with metastases at diagn...

Discussions